Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: Implications in hepatocarcinogenesis

Biochemical and Biophysical Research Communications

Volumn 322, Issue 1, 2004, Pages 297-302

  Arakawa, Yasuo ^a,b   Kajino, Kazunori ^a   Kano, Sayaka ^a   Tobita, Hiroshi ^a   Hayashi, Junpei ^a   Yasen, Mahamute ^a   Moriyama, Mitsuhiko ^b   Arakawa, Yasuyuki ^b   Hino, Okio ^a  

^a CANCER INSTITUTE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

dbpA; DP 1; E2F1; Hepatocarcinogenesis

Indexed keywords

DNA BINDING PROTEIN; DNA BINDING PROTEIN A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL STRAIN HUH 7; CONTROLLED STUDY; DNA BINDING; ENHANCER REGION; GENE DELETION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SYNTHESIS REGULATION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 4143131406     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.208     Document Type: Article

References (34)

1. H. Sakura, T. Maekawa, and F. Imamoto Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology Gene 73 1988 499 507
2. A.P. Wolffe Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins Bioessays 16 1994 245 251
3. K. Matsumoto, and A.P. Wolffe Gene regulation by Y-box proteins: coupling control of transcription and translation Trends Cell. Biol. 8 1998 318 323
4. R.C. Bargou, K. Jurchott, and C. Wagener Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression Nat. Med. 3 1997 447 450
5. K. Shibahara, K. Sugio, and T. Osaki Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer Clin. Cancer Res. 7 2001 3151 3155
6. Y. Ito, H. Yoshida, and K. Shibahara Y-box binding protein expression in thyroid neoplasms: its linkage with anaplastic transformation Pathol. Int. 53 2003 429 433
7. K. Shibao, H. Takano, and Y. Nakayama Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas Int. J. Cancer 83 1999 732 737
8. K. Kajino, T. Yamamoto, and J. Hayashi Recombination hot spot of hepatitis B virus genome binds to members of the HMG domain protein family and the Y box binding protein family; implication of these proteins in genomic instability Intervirology 44 2001 311 316
9. S. Kudo, M.G. Mattei, and M. Fukuda Characterization of the gene for dbpA, a family member of the nucleic-acid-binding proteins containing a cold shock domain Eur. J. Biochem. 231 1995 72 82
10. T. Heinemeyer, E. Wingender, and I. Reuter Databases on Transcriptional Regulation: TRANSFAC, TRRD, and COMPEL Nucleic. Acids. Res. 26 1998 364 370
11. E.A. Conner, E.R. Lammer, and M. Omori Dual functions of E2F1 in a transgenic mouse model of liver carcinogenesis Oncogene 19 2000 5054 5062
12. P.L. Felgner, T.R. Gadek, and M. Holm Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure Proc. Natl. Acad. Sci. USA 84 1987 7413 7417
13. G. Grentzmann, J.A. Ingram, and P.J. Kelly A dual-luciferase reporter system for studying recoding signals RNA 4 1998 479 486
14. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
15. J. Sambrook, and D.W. Russel Molecular Cloning A Laboratory Manual third ed. 2001 Cold Spring Harbor Laboratory Press New York
16. Y. Li, J.E. Slansky, and D.J. Myers Cloning, chromosomal location, and characterization of mouse E2F1 Mol. Cell. Biol. 14 1994 1861 1869
17. K. Kohno, H. Izumi, and T. Uchiumi The pleiotropic functions of the Y-box-binding protein, YB-1 Bioessays 25 2003 691 698
18. L. Levy, C.A. Renard, and Y. Wei Genetic alterations and oncogenic pathways in hepatocellular carcinoma Ann. NY Acad. Sci. 963 2002 21 36
19. H. Nagai, and M.A. Buendia Oncogenes, tumor suppressors and co-factors in hepatocellular carcinoma R. Koshy W. Caselman Hepatitis B Viruses: Molecular Mechanisms in Disease and Novel Strategies for Therapy 1998 Imperial college press London 182 218
20. R.M. Pascale, M.M. Simile, and M.R.D. Miglio Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis Hepatology 35 2002 1341 1350
21. K. Yasui, H. Okamoto, and S. Arii Association of over-expressed TFDP1 with progression of hepatocellular carcinoma J. Hum. Genet. 48 2003 609 613
22. H.E. Huber, G. Edwards, and P.J. Goodhart Transcription factor E2F binds DNA as a heterodimer Proc. Natl. Acad. Sci. USA 90 1993 3525 3529
23. K. Helin, C.L. Wu, and A.R. Fattaey Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation Genes Dev. 7 1993 1850 1861
24. C.L. Wu, L.R. Zukerberg, and C. Ngwu In vivo association of E2F1 and DP family proteins Mol. Cell. Biol. 15 1995 2536 2546
25. K. Yasui, S. Arii, and C. Zhao TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas Hepatology 35 2002 1476 1484
26. L.M. Bennett, P.J. Farnham, and N.R. Drinkwater Strain-dependent differences in DNA synthesis and gene expression in the regenerating livers of C57BL6/6J and C3H/HeJ Mice Mol. Carcinog. 14 1995 46 52
27. D.G. Johnson, J.K. Schwarz, and W.D. Cress Expression of transcription factor E2F1 induces quiescent cells to enter S phase Nature 365 1993 349 352
28. H. Cam, and B.D. Dynlacht Emerging roles for E2F: beyond the G1/S transition and DNA replication Cancer Cell 3 2003 311 316
29. X. Wu, and A.J. Levine p53 and E2F-1 cooperate to mediate apoptosis Proc. Natl. Acad. Sci. USA 91 1994 3602 3606
30. X.Q. Qin, D.M. Livingston, and W.G. Kaelin Jr. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis Proc. Natl. Acad. Sci. USA 91 1994 10918 10922
31. C.T. Guy, W. Zhou, and S. Kaufman E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes Mol. Cell. Biol. 16 1996 685 693
32. D.G. Johnson, W.D. Cress, and L. Jakoi Oncogenic capacity of the E2F1 gene Proc. Natl. Acad. Sci. USA 91 1994 12823 12827
33. H. Pan, C. Yin, and N.J. Dyson Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors Mol. Cell 2 1998 283 292
34. D.K. Dimova, O. Stevaux, and M.V. Frolov Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway Genes Dev. 17 2003 2308 2320